Effectiveness of hepatitis-B vaccination in Ivory Coast: The case of the Grand Bassam health district

Annals of Tropical Medicine and Parasitology

Volumn 103, Issue 6, 2009, Pages 519-527

  Magoni, M ^a,d   Ekra, K D ^b   Aka, L N ^b   Sita, K S ^c   Kanga, K ^d  

^a Fondazione Terre des Hommes Italia   (Italy)

^b Institut National d'Hygiene Publique   (Côte d’Ivoire)

^c Bureau Abidjan à l'Institut National d'Hygiène Publique   (Côte d’Ivoire)

^d District Sanitaire de Grand Bassam ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COTE D'IVOIRE; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; RURAL AREA; SEROLOGY; SEROPREVALENCE; URBAN AREA; VACCINATION; VIRUS CARRIER;

ADULT; CHILD, PRESCHOOL; COTE D'IVOIRE; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; PREGNANCY; PREVALENCE; PROGRAM EVALUATION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 70349189525     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485909X451816     Document Type: Article

References (19)

1. Anon. (1992). Expanded Programme on Immunization. Global Advisory Group - Part I. Weekly Epidemiological Record, 67, 11-15.
2. Anon. (2006). Résultats de l'Enquête Nationale à Indicateurs Multiples, Côte d'Ivoire 2006, Rapport Préliminaire, Abidjan: United Nations Children's Fund.
3. Aplogan, A., Boukalo, K., Kandolo, P., Kondji Kondji, D., Ouattara Siguifota, C., Satoulou, A., Sawadogo, A., Yao, K. & Ziao, A. M. C. (2006). Revue Externe 2006 du Programme É largi de Vaccination. Rapport Final. Abidjan: Ministère de la Santé et de l'Hygiène Publique.
4. Chang, M. H., Chen, C. J., Lai, M. S., Hsu, H. M., Wu, T. C., Kong, M. S., Liang, D. C., Shau, W. Y. & Chen, D. S. (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New England Journal of Medicine, 336, 1855-1859. (Pubitemid 27263972)
5. Chongsrisawat, V., Yoocharoen, P., Theamboonlers, A., Tharmaphornpilas, P., Warinsathien, P., Sinlaparatsamee, S., Paupunwatana, S., Chaiear, K., Khwanjaipanich, S. & Poovorawan, Y. (2006). Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Tropical Medicine and International Health, 11, 1496-1502. (Pubitemid 44450554)
6. Dentinger, C. M., McMahon, B. J., Butler, J. C., Dunaway, C. E., Zanis, C. L., Bulkow, L. R., Bruden, D. L., Nainan, O. V., Khristova, M. L., Hennessy, T. W. & Parkinson, A. J. (2005). Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatric Infectious Disease Journal, 24, 786-792.
7. Kane, M. A. (1996). Global status of hepatitis B immunization. Lancet, 348, 696.
8. Ni, Y. H., Huang, L. M., Chang, M. H., Yen, C. J., Lu, C. Y., You, S. L., Kao, J. H., Lin, Y. C., Chen, H. L., Hsu, H. Y. & Chen, D. S. (2007). Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology, 132, 1287-1293.
9. Reda, A. A., Arafa, M. A., Youssry, A. A., Wandan, E. H., Ab de Ati, M. & Daebees, H. (2003). Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt. European Journal of Epidemiology, 18, 1007-1011. (Pubitemid 37288117)
10. Rouet, F., Chaix, M. L., Inwoley, A., Msellati, P., Viho, I., Combe, P., Leroy, V., Dabis, F. & Rouzioux, C. (2004). HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cô te d'Ivoire: the ANRS 1236 study. Journal of Medical Virology, 74, 34-40. (Pubitemid 38988857)
11. Schoub, B. D., Matai, U., Singh, B., Blackburn, N. K. & Levin, J. B. (2002). Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bulletin of the World Health Organization, 80, 277-281. (Pubitemid 34492287)
12. Soderstrom, A., Norkrans, G. & Lindh, M. (2003). Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scandinavian Journal of Infectious Diseases, 35, 814-819. (Pubitemid 38028916)
13. Tsebe, K. V., Burnett, R. J., Hlungwani, N. P., Sibara, M. M., Venter, P. A. & Mphahlele, M. J. (2001). The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine, 19, 3919-3926.
14. Van der Sande, M. A., Waight, P., Mendy, M., Rayco-Solon, P., Hutt, P., Fulford, T., Doherty, C., McConkey, S. J., Jeffries, D., Hall, A. J. & Whittle, H. C. (2006). Long-term protection against carriage of hepatitis B virus after infant vaccination. Journal of Infectious Diseases, 193, 1528-1535. (Pubitemid 43794582)
15. Wang, Z., Zhang, J., Yang, H., Li, X., Wen, S., Guo, Y., Sun, J. & Hou, J. (2003). Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. Journal of Medical Virology, 71, 360-366. (Pubitemid 37176624)
16. Whittle, H., Jaffar, S., Wansbrough, M., Mendy, M., Dumpis, U., Collinson, A. & Hall, A. (2002). Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. British Medical Journal, 325, 569. (Pubitemid 35026128)
17. World Health Organization (1991). The EPI Coverage Survey. Document WHO/EPI/MLM/91.10. Geneva: WHO.
18. World Health Organization (2001). Introduction of Hepatitis B vaccine into Childhood Immunization Services. Document WHO/V&B/01.316. Geneva: WHO.
19. World Health Organization (2002). Hepatitis B. Document WHO/CDS/CSR/LYO/2002.2. Geneva: WHO.